{
  "cik": 1745999,
  "cik_padded": "0001745999",
  "entityName": "Beam Therapeutics Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-065194",
      "filed": "2026-02-24",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 14946000.0,
        "cash": 294944000.0,
        "eps_diluted": -0.81,
        "free_cash_flow": -360048000.0,
        "net_income": -79992000.0,
        "operating_cash_flow": -345102000.0,
        "operating_income": -383693000.0,
        "revenue": 139743000.0,
        "stockholders_equity": 1238358000.0,
        "total_assets": 1481177000.0,
        "total_liabilities": 242819000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.19608142395010167,
        "net_margin": -0.5724222322406132,
        "revenue_growth_yoy": 1.2000535281337574,
        "roa_avg2y": -0.061889337760410924,
        "roa_period_end": -0.054005699521394133,
        "roe_avg2y": -0.0811317798086417,
        "roe_period_end": -0.06459521398497042
      }
    },
    {
      "accn": "0001193125-26-065194",
      "filed": "2026-02-24",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 8946000.0,
        "cash": 281967000.0,
        "eps_diluted": -4.58,
        "free_cash_flow": -356192000.0,
        "net_income": -376742000.0,
        "operating_cash_flow": -347246000.0,
        "operating_income": -415568000.0,
        "revenue": 63518000.0,
        "stockholders_equity": 733545000.0,
        "total_assets": 1103824000.0,
        "total_liabilities": 370279000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.5047802111663224,
        "revenue_growth_yoy": -0.8318335014521762,
        "roa_avg2y": -0.2939234760709613,
        "roa_period_end": -0.34130622273116,
        "roe_avg2y": -0.4393815522306595,
        "roe_period_end": -0.5135908499137749
      }
    },
    {
      "accn": "0001193125-26-065194",
      "filed": "2026-02-24",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 33732000.0,
        "cash": 435895000.0,
        "eps_diluted": -1.72,
        "free_cash_flow": -182927000.0,
        "net_income": -132527000.0,
        "operating_cash_flow": -149195000.0,
        "operating_income": -176485000.0,
        "revenue": 377709000.0,
        "stockholders_equity": 981329000.0,
        "total_assets": 1459714000.0,
        "total_liabilities": 478385000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4874868672993461,
        "net_margin": -0.35087064380250405,
        "operating_margin": -0.4672512436823057,
        "revenue_growth_yoy": 5.200082074852265,
        "roa_avg2y": -0.09461388977335844,
        "roa_period_end": -0.09078970264038023,
        "roe_avg2y": -0.15456819238128228,
        "roe_period_end": -0.13504849036357838
      }
    },
    {
      "accn": "0001193125-26-065194",
      "filed": "2026-02-24",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 48951000.0,
        "cash": 232767000.0,
        "eps_diluted": -4.13,
        "free_cash_flow": -26424000.0,
        "net_income": -289088000.0,
        "operating_cash_flow": 22527000.0,
        "operating_income": -338479000.0,
        "revenue": 60920000.0,
        "stockholders_equity": 733474000.0,
        "total_assets": 1341714000.0,
        "total_liabilities": 608240000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.8292591148425166,
        "revenue_growth_yoy": 0.17506365249594938,
        "roa_avg2y": -0.20530600635544696,
        "roa_period_end": -0.21546171538792916,
        "roe_avg2y": -0.370575280795174,
        "roe_period_end": -0.39413530677297354
      }
    },
    {
      "accn": "0000950170-25-026076",
      "filed": "2025-02-25",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 46811000.0,
        "cash": 559994000.0,
        "eps_diluted": -5.77,
        "free_cash_flow": -113079000.0,
        "net_income": -370638000.0,
        "operating_cash_flow": -66268000.0,
        "operating_income": -392465000.0,
        "revenue": 51844000.0,
        "stockholders_equity": 826738000.0,
        "total_assets": 1474453000.0,
        "total_liabilities": 647715000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7834586047816842,
        "revenue_growth_yoy": 2159.1666666666665,
        "roa_avg2y": -0.3848525281263466,
        "roa_period_end": -0.2513732211199679,
        "roe_avg2y": -0.6912959911368005,
        "roe_period_end": -0.44831373421809567
      }
    },
    {
      "accn": "0000950170-24-020622",
      "filed": "2024-02-27",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 16357000.0,
        "cash": 162171000.0,
        "eps_diluted": -4.19,
        "free_cash_flow": -112098000.0,
        "net_income": -194592000.0,
        "operating_cash_flow": -95741000.0,
        "operating_income": -132760000.0,
        "revenue": 24000.0,
        "stockholders_equity": 245561000.0,
        "total_assets": 451677000.0,
        "total_liabilities": 206116000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.8393678149217506,
        "revenue_growth_yoy": 0.3333333333333333,
        "roa_avg2y": -0.640341178328858,
        "roa_period_end": -0.4308211398853606,
        "roe_avg2y": -8.754166947837236,
        "roe_period_end": -0.7924385386930335
      }
    },
    {
      "accn": "0000950170-23-004866",
      "filed": "2023-02-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 12518000.0,
        "cash": 37221000.0,
        "eps_diluted": -14.05,
        "free_cash_flow": -84521000.0,
        "net_income": -78326000.0,
        "operating_cash_flow": -72003000.0,
        "operating_income": -75154000.0,
        "revenue": 18000.0,
        "stockholders_equity": -201104000.0,
        "total_assets": 156099000.0,
        "total_liabilities": 55154000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.5017713117957194,
        "roe_avg2y": 0.4918275721327431
      }
    },
    {
      "accn": "0000950170-22-002166",
      "filed": "2022-02-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -117406000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-065194",
    "filed": "2026-02-24",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001745999.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001745999.json"
  },
  "ticker": "BEAM"
}